Drugs / Cellspan™ Esophageal Implant-Adult
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05877300 | Jul 2023 → Jul 2026 overdue | esophageal disorder | Harvard Apparatus Regenerative Technology, Inc. | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cellspan Esophageal Implant-Adult | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05877300 ↗ |
| Known as | CEI | “Cellspan™ Esophageal Implant-Adult (CEI)” NCT05877300 ↗ |
| Route | Other | “The CEI will be surgically implanted” NCT05877300 ↗ |